Veraxa Biotech AG VRXA
0.95 USD 0.00 (-0.23%)
At closeNov 6, 2026, 4:00 PM EST
0.95 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
0.90 Day range 0.97
0.90 52-week range 27.36
- YTD
- -91.10%
- 1 year
- -90.96%
News
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers Immuron (NASDAQ:IMRN) shares moved upwards by 48.2% to $1.65 during Friday's regular session. The market value of their outstanding shares is at $8.9 million. bioAffinity Technologies…
benzinga.com VERAXA Biotech Announces Initial Results From Strategic Research Collaboration To Develop Next-Generation Antibody Oligonucleotide Conjugates For Autoimmune And Chronic Immune Diseases; In Early In Vitro Studies, An AOC Candidate Demonstrated Greater Potency VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA"))), an emerging leader in the design and development of next-generation cancer therapeutics, and Secarna Pharmaceuticals GmbH & Co. KG ("Secarna"), a company
benzinga.com VERAXA Biotech Advances Bispecific ADC VXA‑222 With OmniAb Milestone, Moving Alliance Into Next Phase Of Cancer Therapy Discovery VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA" or the ", Company", ))), an emerging leader in designing novel cancer therapies, today announced the advancement of bispecific ADC (bsADC) program VXA-222,
benzinga.com VERAXA Gets German Regulatory Feedback On Cancer Therapy Plan VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA))), an emerging leader in designing novel cancer therapies, today announced that it has received Scientific Advice from the German regulatory authority, the
benzinga.com VERAXA Biotech Partners With AI-Driven Computational R&D Partner Ardigen To Support Its Growing BiTAC Pipeline Of T Cell Engagers And Antibody Drug Conjugates The collaboration is another milestone in VEREXA’s mission to integrate AI into its research and development, with the long-term goal to achieve success rates in drug development that exceed industry…
benzinga.com FB Financial, Smith Micro Software And 3 Stocks To Watch Heading Into Monday U.S. stock futures down today, FB Financial, Smith Micro Software, LogProstyle, Veraxa Biotech, and Q32 Bio among stocks to watch. More premarket coverage at Benzinga.- benzinga.com VERAXA Biotech Appoints Carl Von Halem As Interim CFO, Succeeding Torsten Bürgermeister VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA"))), an emerging leader in designing novel cancer therapies, today announced the appointment of Carl von Halem as Interim Chief Financial Officer. He succeeds…
benzinga.com Penguin Solutions, Beazer Homes, Alibaba And Other Big Stocks Moving Higher On Wednesday U.S. stocks fell, Nasdaq down 100 points. Penguin Solutions Inc (PENG) rose 18.8% after better-than-expected earnings. Other big gainers: PRME, BZH, WULF, VRXA, BABA, ACDC, KC, PARR, SWMR, BBOT, KEX
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers Crinetics Pharmaceuticals (NASDAQ:CRNX) shares moved upwards by 98.7% to $83.53 during Tuesday's regular session. The company's market cap stands at $4.4 billion. Tvardi Therapeutics…- benzinga.com VERAXA Biotech Channels Investment Into BiTAC Portfolio, Eyes BiTAC-TCE Candidate VXA-102 IND/CTA-Ready By 2028 VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA"))), an emerging leader in designing novel cancer therapies, today provided a company and pipeline update."In the first six months of 2026, we have made…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Seer (NASDAQ:SEER) stock moved upwards by 33.3% to $2.16 during Thursday's after-market session. The market value of their outstanding shares is at $89.6 million. Universe Pharmaceuticals…- benzinga.com 11 Health Care Stocks Moving In Thursday's Intraday Session Gainers Chemomab Therapeutics (NASDAQ:CMMB) stock increased by 33.8% to $2.27 during Thursday's regular session. The market value of their outstanding shares is at $12.2 million. Liminatus Pharma…
- benzinga.com Veraxa Biotech Initiated Cell Line Development For Its Lead BiTAC T-cell Engager Program VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA"))), an emerging leader in designing novel cancer therapies, today announced the initiation of cell line development for its lead BiTAC® T-cell engager…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Pulsenmore (NASDAQ:PLSM) shares moved upwards by 160.5% to $8.88 during Wednesday's regular session. The market value of their outstanding shares is at $22.1 million. Icecure Medical…
benzinga.com VERAXA Biotech Moves Into Additional Laboratory Space At Existing R&D Site In Heidelberg, Germany, To Support Team Growth And Infrastructure Build‑Out VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA"))), an emerging leader in designing novel cancer therapies, today announced that the Company has moved into additional laboratory space at its existing R&D…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers Aditxt (NASDAQ:ADTX) shares increased by 151.6% to $0.05 during Tuesday's regular session. Atlantic International (NASDAQ:ATLN) stock rose 143.31% to $1.07. The market value of their…
benzinga.com Sophia Genetics, Ormat Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session U.S. stock futures mostly higher, Nasdaq futures gain 100+ points. Sophia Genetics (SOPH) falls after pricing public offering of $50M. Other stocks decline in pre-market.
benzinga.com Why La-Z-Boy Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket Shares of La-Z-Boy Inc (NYSE: LZB) rose 19.6% in pre-market trading after reporting better-than-expected results and announcing a $300 million share buyback.
benzinga.com Crude Oil Down Over 3%; US Consumer Sentiment Rises In June Dow Jones up 0.56%, NASDAQ up 0.08%, S&P 500 up 0.32%. Materials shares rise 1.7%, consumer discretionary down 1.3%. University of Michigan's consumer sentiment index beats estimates. Oil down 3.3%,…
benzinga.com VERAXA Biotech And Voyager Acquisition Complete Business Combination; On June 11, 2026, VERAXA Will Commence Trading Its Shares Under The Symbol "VRXA" Business combination transaction with Voyager Acquisition Corp. complete, creating a Nasdaq-listed, innovative biopharmaceutical company focused on next-generation cancer therapies of novel…